Drug Shortage Report for BIPAZEN

Last updated on 2024-07-15 History
Report ID 232584
Drug Identification Number 02513579
Brand name BIPAZEN
Common or Proper name Desmopressin Acetate Injection
Company Name KVR PHARMACEUTICALS INC.
Market Status MARKETED
Active Ingredient(s) DESMOPRESSIN ACETATE
Strength(s) 4MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size Cartons of 10 ampoules
ATC code H01BA
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-07-19
Actual start date
Estimated end date 2024-10-01
Actual end date
Shortage status Anticipated shortage
Updated date 2024-07-15
Company comments Discovered a quality issue with the lot of glass ampoules to be used in the next production. A new lot of glass ampoules have been ordered for rush delivery. Upon arrival, a new Bipazen batch will be produced.
Health Canada comments
Tier 3 Status No
Contact Address 21 PARR BLVD, UNIT 12
CALEDON, ONTARIO
CANADA L7E 4G3
Company contact information 1 877 302 2561 ext 101 info@kvrpharma.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-07-15 French Compare
v9 2024-07-15 English Compare
v8 2024-07-09 French Compare
v7 2024-07-09 English Compare
v6 2024-07-09 French Compare
v5 2024-07-09 English Compare
v4 2024-07-09 French Compare
v3 2024-07-09 English Compare
v2 2024-07-09 English Compare
v1 2024-07-09 English Compare

Showing 1 to 10 of 10